After nearly a decade of treatment, a Texas woman reached remission through an FDA-approved cellular therapy for chronic ...

CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone ...

Ebvallo is one of a series of rare disease treatments recently turned back by the FDA amid shifting guidance that has ...

The first engineered cell therapy has come to the fight against solid tumors. Fox Chase Cancer Center has begun using Tecelra, an FDA-approved treatment for synovial sarcoma.

Six pregnant women participated in a small trial in which placenta-derived stem cells were applied to fetal spinal cords and the treatment was found to be safe.

A Japanese research team has demonstrated in rat experiments that stem cells from human primary tooth pulp may help treat ...

Florida patients can now access umbilical stem cell treatments and bank a lifetime supply of their own stem cells ...

A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...

Johnson & Johnson, the healthcare and lifestyle giant announced a more than $1 billion dollar investment in next generation ...

With $55 billion earmarked to bolster its U.S. operations, Johnson & Johnson is the latest drugmaker to zero in on expansion ...

Once fully operational, the Pennsylvania site will employ more than 500 people and make cell therapies for thousands of patients a year.